Protein Targets of Oxidative Damage in Human Neurodegenerative Diseases with Abnormal Protein Aggregates

Abstract

Human neurodegenerative diseases with abnormal protein aggregates are associated with aberrant post-translational modifications, solubility, aggregation and fibril formation of selected proteins which cannot be degraded by cytosolic proteases, ubiquitin-protesome system and autophagy, and, therefore, accumulate in cells and extracellular compartments as residual debris. In addition to the accumulation of "primary" proteins, several other mechanisms are involved in the degenerative process and probably may explain crucial aspects such as the timing, selective cellular vulnerability and progression of the disease in particular individuals. One of these mechanisms is oxidative stress, which occurs in the vast majority of, if not all, degenerative diseases of the nervous system. The present review covers most of the protein targets that have been recognized as modified proteins mainly using bidimensional gel electrophoresis, Western blotting with oxidative and nitrosative markers, and identified by mass spectrometry in Alzheimer disease; certain tauopathies such as progressive supranuclear palsy, Pick disease, argyrophilic grain disease and frontotemporal lobar degeneration linked to mutations in tau protein, for example, FTLD-tau, Parkinson disease and related a-synucleinopathies; Huntington disease; and amyotrophic lateral sclerosis, together with related animal and cellular models. Vulnerable proteins can be mostly grouped in defined metabolic pathways covering glycolysis and energy metabolism, cytoskeletal, chaperoning, cellular stress responses, and members of the ubiquitin-proteasome system. Available information points to the fact that vital metabolic pathways are hampered by protein oxidative damage in several human degenerative diseases and that oxidative damage occurs at very early stages of the disease. Yet parallel functional studies are limited and further work is needed to document whether protein oxidation results in loss of activity and impaired performance. A better understanding of proteins susceptible to oxidation and nitration may serve to define damaged metabolic networks at early stages of disease and to advance therapeutic interventions to attenuate disease progression.

Protein Oxidation in Aging: Does It Play a Role in Aging Progression?

“…Moreover, some studies have demonstrated in detail which proteins are oxidatively damaged (110). Oxidized proteins detected in NDs can be divided into different functional groups: (i) glycolysis and energy metabolism, (ii) mitochondrial proteins, (iii) cytoskeleton, (iv) chaperones, and (v) members of the UPS.…”

Enhanced protein repair and recycling are not correlated with longevity in 15 vertebrate endotherm species

“…Exposure to oxidative stress can lead to oxidative protein damage that directly alters protein structure, leading to dramatic decreases in their activity and/or aggregation of partially denatured proteins. Aberrant protein aggregation in brain tissue is a key feature of the major neurodegenerative disorders associated with aging (Martinez et al 2008). To maintain protein function in the face of oxidative stress, cells utilize "protein repair" enzymes, capable of maintaining protein redox homeostasis through the regulation of thiol-disulfide exchange on critical residues, particularly cysteine.…”

The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells

“…[1][2][3][4][5][6] Age-related macular degeneration (AMD) is a neurodegenerative disease of the eye and the leading cause of central blindness in western countries. 7,8 Currently, for 80% to 85% of the 30 to 50 million AMD patients worldwide there are no effective treatment alternatives.…”